Single-Dose – News & Updates

FDA Approves First-in-Class Microbiota-Based Live Biotherapeutic for C. Difficile Infection

adminDecember 4, 20220718 views

Summary- The FDA has approved fecal microbiota, live-jslm (Rebyota; Ferring Pharmaceuticals) for the prevention of recurring Clostridioides difficile infection (CDI) among patients 18…

Glenmark Pharmaceuticals receives ANDA tentative approval for Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL) Single-Dose Pre-Filled Syringe

adminJanuary 17, 20220625 views

Synopsis : Glenmark Pharmaceuticals Inc., USA (Glenmark) has received tentative approval by the United States Food & Drug Administration (U.S. FDA) for Regadenoson Injection,…